ClinConnect ClinConnect Logo
Search / Trial NCT05511610

MAAS Method (Minimal-flow Auto-control Anesthesia System) for the Administration of Desflurane and Sevoflurane

Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SEVILLA · Aug 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sevoflurane Desflurane Anesthesia, Closed Circuit

ClinConnect Summary

The MAAS Method clinical trial is looking at a new way to deliver anesthesia during certain types of surgeries, specifically using two anesthetic gases called sevoflurane and desflurane. The goal is to see how accurately a special device called the Minimal-flow Autocontrol Anesthesia System can provide the right amount of these gases to keep patients comfortable and safe while they are under anesthesia. Researchers will monitor how many times adjustments need to be made to keep the levels of anesthesia steady and will also check how long it takes to reach the desired levels.

To be part of this study, participants must be adults scheduled for specific robotic surgeries and must provide written consent. However, certain health conditions, such as severe lung disease or heart issues, may exclude individuals from participating. Those who join the trial can expect to receive tailored care during their procedure, focused on maintaining their lung function. Your participation will help researchers better understand how to improve anesthesia delivery for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult subjects (≥ 18 years) scheduled for robotic urological, coloproctological or gynecological surgery in the investigators´ institution
  • Written informed consent
  • Exclusion Criteria:
  • Participation in another interventional study
  • Participants unable to understand the information contained in the informed consent
  • American Society of Anesthesiologists (ASA) classification grade = IV
  • Patient in dialysis
  • Chronic obstructive pulmonary disease (COPD) grade Global Initiative for Chronic Obstructive Lung Disease(GOLD) \> 2
  • Functional vital capacity \< 60% or \> 120% of the predicted
  • Body mass index (BMI) \> 35 kg/m2
  • New York Heart Association (NYHA) functional class ≥ 3
  • Clinically suspected heart failure
  • Diagnosis or suspicion of intracranial hypertension
  • Presence of pneumothorax or giant bullae on preoperative imaging tests
  • Use of Continuous Positive Airway Pressure (CPAP).

About Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla

The Fundación Pública Andaluza para la Gestión de la Investigación en Sevilla is a public foundation dedicated to advancing clinical research and innovation within the Andalusian healthcare system. By fostering collaboration among healthcare professionals, researchers, and institutions, the foundation aims to enhance the quality and efficiency of clinical trials. With a strong focus on ethical standards and regulatory compliance, it plays a pivotal role in supporting the development of new therapies and improving patient outcomes in the region. Through its commitment to scientific excellence and community health, the foundation contributes significantly to the advancement of medical knowledge and practice.

Locations

Sevilla, , Spain

Patients applied

0 patients applied

Trial Officials

Manuel de la Matta, PhD

Principal Investigator

Hospitales Universitarios Virgen del Rocío

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials